Clinical activity, safety, and biomarkers of MPDL3280A, an engineered PD-L1 antibody in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).
David R. Spigel
Consultant or Advisory Role - Genentech
Scott N. Gettinger
No relevant relationships to disclose
Leora Horn
Consultant or Advisory Role - Astellas Pharma (U); Boehringer Ingelheim (U); Genentech (U); OSI Pharmaceuticals (U)
Research Funding - Astellas Pharma; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis; Genentech; Xcovery
Roy S. Herbst
Research Funding - Genentech
Leena Gandhi
No relevant relationships to disclose
Michael S. Gordon
Consultant or Advisory Role - Genentech
Research Funding - Genentech/Roche
Cristina Cruz
No relevant relationships to disclose
Paul Conkling
Research Funding - US Oncology
Philippe Alexandre Cassier
Research Funding - Roche
Scott J. Antonia
No relevant relationships to disclose
Howard A. Burris
No relevant relationships to disclose
Gregg Daniel Fine
Employment or Leadership Position - Genentech/Roche
Stock Ownership - Genentech/Roche
Ahmad Mokatrin
Employment or Leadership Position - Genentech/Roche
Stock Ownership - Genentech/Roche
Marcin Kowanetz
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Xiaodong Shen
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Daniel S. Chen
Employment or Leadership Position - Genentech
Stock Ownership - Genentech/Roche
Jean-Charles Soria
Consultant or Advisory Role - Roche
Honoraria - Roche